摘要:
elsevier.com
sci-hub.se 参考文章(17)
B. Fisher, J. Dignam, J. Bryant, A. DeCillis, D. L. Wickerham, N. Wolmark, J. Costantino, C. Redmond, E. R. Fisher, D. M. Bowman, L. Deschenes, N. V. Dimitrov, R. G. Margolese, A. Robidoux, H. Shibata, J. Terz, A. H. G. Paterson, M. I. Feldman, W. Farrar, J. Evans, H. L. Lickley, Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors Journal of the National Cancer Institute. ,vol. 88, pp. 1529- 1542 ,(1996) , 10.1093/JNCI/88.21.1529
R. Peto, Five Years of Tamoxifen—or More? Journal of the National Cancer Institute. ,vol. 88, pp. 1791- 1793 ,(1996) , 10.1093/JNCI/88.24.1791
Gibson T, Ross Ds, INFECTION IN INFANCY. The Lancet. ,vol. 1, pp. 257- 258 ,(1965)
Powles Tj, Efficacy of tamoxifen as treatment of breast cancer. Seminars in Oncology. ,vol. 24, ,(1997)
Lesser M, Schreiber K, Oberlander Sg, Koss Lg, Moussouris Hf, Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstetrics & Gynecology. ,vol. 64, pp. 1- 11 ,(1984)
Tamoxifen for early breast cancer: An overview of the randomised trials The Lancet. ,vol. 351, pp. 1451- 1467 ,(1998) , 10.1016/S0140-6736(97)11423-4
I A Jaiyesimi, A U Buzdar, D A Decker, G N Hortobagyi, Use of tamoxifen for breast cancer: twenty-eight years later. Journal of Clinical Oncology. ,vol. 13, pp. 513- 529 ,(1995) , 10.1200/JCO.1995.13.2.513
Richard R. Love, Richard B. Mazess, Howard S. Barden, Sol Epstein, Polly A. Newcomb, V. Craig Jordan, Paul P. Carbone, David L. DeMets, Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer The New England Journal of Medicine. ,vol. 326, pp. 852- 856 ,(1992) , 10.1056/NEJM199203263261302
J. A. Dewar, J. M. Horobin, P. E. Preece, R. Tavendale, H. Tunstall-Pedoe, R. A. Wood, Long term effects of tamoxifen on blood lipid values in breast cancer. BMJ. ,vol. 305, pp. 225- 226 ,(1992) , 10.1136/BMJ.305.6847.225
R. R. Love, D. A. Wiebe, J. M. Feyzi, P. A. Newcomb, R. J. Chappell, Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of Treatment Journal of the National Cancer Institute. ,vol. 86, pp. 1534- 1539 ,(1994) , 10.1093/JNCI/86.20.1534